What a Large 2026 Study Reveals About GLP-1 Medications and Hair Loss
Semaglutide hair loss risk emerged as a significant signal in a large propensity-matched cohort study involving hundreds of thousands of patients. Researchers found higher rates of nonscarring hair loss among semaglutide and tirzepatide users compared…
Hair Shedding, Weight Loss, and GLP-1 Therapy: Separating Signal from Speculation
GLP-1 hair loss risk has become a growing concern as semaglutide and tirzepatide use expands. A large propensity-matched cohort study found significantly higher rates of nonscarring hair loss among users of both medications compared with metformin. The…
Clinical Evidence on Semaglutide and Hair Loss
Semaglutide hair loss clinical evidence highlights a potential link between this GLP-1 receptor agonist and telogen effluvium. This side effect is generally temporary and related to rapid weight loss. Clinicians should counsel patients on this risk to…
